GlassScriptPhysician profile
Roland K Huffaker
NPI 1881608693
$17,108.52
in general payments reported to CMS, 2019-2025
13 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what 80% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.24 · 2020: $44.81 · 2021: $78.04 · 2022: $169 · 2023: $15K · 2024: $443 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $1,789 · Food and Beverage: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,509.07 |
| Travel and Lodging | $1,789.47 |
| Food and Beverage | $1,500.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,739.26 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $943.16 | 2021-2025 | Interstim |
| Applied Medical Resources Corporation | $695.23 | 2025 | Gelpoint V-Path |
| Sumitomo Pharma America, INC. | $219.63 | 2025 | Gemtesa |
| Abbvie INC. | $174.80 | 2021-2025 | |
| Boston Scientific Corporation | $115.61 | 2024-2025 | General - Female Sui, Axonics, Advantage System |
| Axonics, INC. | $59.52 | 2023-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $45.49 | 2022-2025 | Veozah |
| Pfizer INC. | $35.85 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $29.04 | 2024 | Endosheath Technology |
| Urovant Sciences INC | $23.73 | 2022 | |
| Medtronic USA, INC. | $15.53 | 2020 | |
| Olympus America INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roland Huffaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.